market access

Market Access

Trust takes time. But a data-driven digital healthcare syste...

The NHS needs to find a way to put privacy first to build trust with the public around its innovation plans, explains Nigel Jones, co-founder of the Privacy Compliance Hub.

R&D

Trials and tribulations of drug development: What does it ta...

Rare diseases are a complex and challenging area of medicine, affecting millions of people worldwide.

Market Access

Addressing Europe’s plasma deficit

Across the European Union approximately 300,000 patients with chronic conditions, such as haemophilia and severe immune-deficiency, depend on plasma-derived medicines, which can only be man

Market Access

How the hyperlocal delivery model could empower pharmacists ...

The NHS is currently facing significant challenges, including staff shortages, union strikes, supply chain issues, and increasing patient volume.

Market Access

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.

Market Access